---
schema_version: "secwatch.filing_event.v1"
accession: "0001564590-22-033704"
form_type: "8-K"
ticker: "NUVL"
cik: "0001861560"
company_name: "Nuvalent, Inc."
filed_at: "2022-10-06T23:59:59+00:00"
generated_at: "2026-06-23T05:11:08.832955+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Nuvalent elects Dr. Michael L. Meyers to the Board as Class II director

## Summary
- Dr. Meyers was elected independent Class II director effective October 4, 2022.
- He will also serve on the Nominating and Corporate Governance Committee.
- Received initial option grant for 40,000 shares at $19.48 per share, vesting monthly over 3 years.
- Compensation follows Nuvalent's non-employee director policy including annual cash retainers and equity.
- No family relationships or transactions with the Company requiring disclosure.

## SEC filing metadata
- accession: 0001564590-22-033704
- form_type: 8-K
- ticker: NUVL
- cik: 0001861560
- company_name: Nuvalent, Inc.
- filed_at: 2022-10-06T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1861560/000156459022033704/0001564590-22-033704-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1861560/000156459022033704/nuvl-8k_20221004.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001564590-22-033704
- JSON: https://secwatch.observer/filing/0001564590-22-033704.json
- Plain text: https://secwatch.observer/filing/0001564590-22-033704.txt

## Key facts
- Executive change
  Michael L. Meyers was elected as Director at Nuvalent, Inc..
  - Action: elected
  - Role: Director
  source text: On October 4, 2022, in accordance with the recommendation of the Nominating and Corporate Governance Committee (“NCG Committee”) of the Board of Directors (the “Board”) of Nuvalent, Inc. (the “Company”), the Board elected Michael L. Meyers, M.D., Ph.D., as a member of the Board, effective immediately.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1861560/000156459022033704/0001564590-22-033704-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.